GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Insider Ownership

Galderma Group AG (XSWX:GALD) Insider Ownership : 0.00 % (As of Mar. 26, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Galderma Group AG's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Galderma Group AG's Institutional Ownership is 19.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Galderma Group AG's Float Percentage Of Total Shares Outstanding is 0.00%.


Galderma Group AG Insider Ownership Historical Data

The historical data trend for Galderma Group AG's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Insider Ownership Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
Insider Ownership
- -

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
Insider Ownership - - - -

Galderma Group AG Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Galderma Group AG Business Description

Traded in Other Exchanges
Address
Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines